Most patients with migraine who underwent a greater occipital nerve block for treatment reported moderate to significant positive responses, according to findings recently published in the Journal of ...
The new document raises IV prochlorperazine and greater occipital nerve blocks to must-offer status and states that opioids ...
Lidocaine injections into the greater occipital nerve relieve severe, refractory migraine attacks in children, results of a randomized controlled trial show. Investigators found children receiving ...
Study Finds GONB With Bupivacaine Inferior to IV Metoclopramide as First-line Treatment for Migraine
According to a study published in Headache, greater occipital nerve blocks (GONB) with bupivacaine were not as effective as intravenous (IV) metoclopramide as a first-line treatment for migraineurs ...
The American Headache Society updates guidelines on the use of parenteral pharmacologic therapies for migraine attack management in the ED.
People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids to quell their pain, a major update of treatment guidelines suggests. Doctors should use a ...
Nerve blocks are now recommended to treat migraine pain in the ER The block halts pain signals from traveling along the occipital nerves at the base of the skull The new guidelines recommend against ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Neurologist Dr.
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results